▶ 調査レポート

パニック障害の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Panic Disorders Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。パニック障害の世界市場2020年:企業別、地域別、種類・用途別 / Global Panic Disorders Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0GIR-01894資料のイメージです。• レポートコード:D0GIR-01894
• 出版社/出版日:GlobalInfoResearch / 2020年9月23日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、パニック障害の世界市場を広く調査・分析し、今後の市場展望をまとめております。パニック障害の種類別市場規模(抗うつ薬、ベンゾジアゼピン)、用途別市場規模(病院薬局、小売薬局、ドラッグストア、電子商取引)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Teva Pharmaceutical、AstraZeneca、Sun Pharmaceuticals、Mylan
・地域別グローバル市場分析 2015年-2020年
・パニック障害の北米市場(アメリカ、カナダ、メキシコ)
・パニック障害のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・パニック障害のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・パニック障害の南米市場(ブラジル、アルゼンチン)
・パニック障害の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:抗うつ薬、ベンゾジアゼピン
・用途別分析:病院薬局、小売薬局、ドラッグストア、電子商取引
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Panic Disorders market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Panic Disorders market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Panic Disorders market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Panic Disorders market has been segmented into:
Anti-Depressants
Benzodiazepines

By Application, Panic Disorders has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
E-Commerce

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Panic Disorders market presented in the report. This section sheds light on the sales growth of different regional and country-level Panic Disorders markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Panic Disorders market.

The report offers in-depth assessment of the growth and other aspects of the Panic Disorders market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Panic Disorders Market Share Analysis
Panic Disorders competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Panic Disorders sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Panic Disorders sales, revenue and market share for each player covered in this report.

The major players covered in Panic Disorders are:
Teva Pharmaceutical
AstraZeneca
Sun Pharmaceuticals
Mylan

レポート目次

Table of Contents

1 Panic Disorders Market Overview
1.1 Product Overview and Scope of Panic Disorders
1.2 Classification of Panic Disorders by Type
1.2.1 Global Panic Disorders Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Panic Disorders Revenue Market Share by Type in 2019
1.2.3 Anti-Depressants
1.2.4 Benzodiazepines
1.3 Global Panic Disorders Market by Application
1.3.1 Overview: Global Panic Disorders Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 E-Commerce
1.4 Global Panic Disorders Market by Regions
1.4.1 Global Panic Disorders Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Panic Disorders (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Panic Disorders Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Panic Disorders Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Panic Disorders Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Panic Disorders Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Panic Disorders Status and Prospect (2015-2025)
2 Company Profiles
2.1 Teva Pharmaceutical
2.1.1 Teva Pharmaceutical Details
2.1.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva Pharmaceutical SWOT Analysis
2.1.4 Teva Pharmaceutical Product and Services
2.1.5 Teva Pharmaceutical Panic Disorders Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AstraZeneca SWOT Analysis
2.2.4 AstraZeneca Product and Services
2.2.5 AstraZeneca Panic Disorders Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sun Pharmaceuticals
2.3.1 Sun Pharmaceuticals Details
2.3.2 Sun Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sun Pharmaceuticals SWOT Analysis
2.3.4 Sun Pharmaceuticals Product and Services
2.3.5 Sun Pharmaceuticals Panic Disorders Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Mylan SWOT Analysis
2.4.4 Mylan Product and Services
2.4.5 Mylan Panic Disorders Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Panic Disorders Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Panic Disorders Players Market Share
3.2.2 Top 10 Panic Disorders Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Panic Disorders Revenue and Market Share by Regions
4.2 North America Panic Disorders Revenue and Growth Rate (2015-2020)
4.3 Europe Panic Disorders Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Panic Disorders Revenue and Growth Rate (2015-2020)
4.5 South America Panic Disorders Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Panic Disorders Revenue and Growth Rate (2015-2020)
5 North America Panic Disorders Revenue by Countries
5.1 North America Panic Disorders Revenue by Countries (2015-2020)
5.2 USA Panic Disorders Revenue and Growth Rate (2015-2020)
5.3 Canada Panic Disorders Revenue and Growth Rate (2015-2020)
5.4 Mexico Panic Disorders Revenue and Growth Rate (2015-2020)
6 Europe Panic Disorders Revenue by Countries
6.1 Europe Panic Disorders Revenue by Countries (2015-2020)
6.2 Germany Panic Disorders Revenue and Growth Rate (2015-2020)
6.3 UK Panic Disorders Revenue and Growth Rate (2015-2020)
6.4 France Panic Disorders Revenue and Growth Rate (2015-2020)
6.5 Russia Panic Disorders Revenue and Growth Rate (2015-2020)
6.6 Italy Panic Disorders Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Panic Disorders Revenue by Countries
7.1 Asia-Pacific Panic Disorders Revenue by Countries (2015-2020)
7.2 China Panic Disorders Revenue and Growth Rate (2015-2020)
7.3 Japan Panic Disorders Revenue and Growth Rate (2015-2020)
7.4 Korea Panic Disorders Revenue and Growth Rate (2015-2020)
7.5 India Panic Disorders Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Panic Disorders Revenue and Growth Rate (2015-2020)
8 South America Panic Disorders Revenue by Countries
8.1 South America Panic Disorders Revenue by Countries (2015-2020)
8.2 Brazil Panic Disorders Revenue and Growth Rate (2015-2020)
8.3 Argentina Panic Disorders Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Panic Disorders by Countries
9.1 Middle East & Africa Panic Disorders Revenue by Countries (2015-2020)
9.2 Saudi Arabia Panic Disorders Revenue and Growth Rate (2015-2020)
9.3 UAE Panic Disorders Revenue and Growth Rate (2015-2020)
9.4 Egypt Panic Disorders Revenue and Growth Rate (2015-2020)
9.5 South Africa Panic Disorders Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Panic Disorders Revenue and Market Share by Type (2015-2020)
10.2 Global Panic Disorders Market Forecast by Type (2019-2024)
10.3 Anti-Depressants Revenue Growth Rate (2015-2025)
10.4 Benzodiazepines Revenue Growth Rate (2015-2025)
11 Global Panic Disorders Market Segment by Application
11.1 Global Panic Disorders Revenue Market Share by Application (2015-2020)
11.2 Panic Disorders Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Drug Stores Revenue Growth (2015-2020)
11.6 E-Commerce Revenue Growth (2015-2020)
12 Global Panic Disorders Market Size Forecast (2021-2025)
12.1 Global Panic Disorders Market Size Forecast (2021-2025)
12.2 Global Panic Disorders Market Forecast by Regions (2021-2025)
12.3 North America Panic Disorders Revenue Market Forecast (2021-2025)
12.4 Europe Panic Disorders Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Panic Disorders Revenue Market Forecast (2021-2025)
12.6 South America Panic Disorders Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Panic Disorders Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Panic Disorders Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Panic Disorders by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Panic Disorders Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Panic Disorders Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Teva Pharmaceutical Corporate Information, Location and Competitors
Table 6. Teva Pharmaceutical Panic Disorders Major Business
Table 7. Teva Pharmaceutical Panic Disorders Total Revenue (USD Million) (2017-2018)
Table 8. Teva Pharmaceutical SWOT Analysis
Table 9. Teva Pharmaceutical Panic Disorders Product and Solutions
Table 10. Teva Pharmaceutical Panic Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AstraZeneca Corporate Information, Location and Competitors
Table 12. AstraZeneca Panic Disorders Major Business
Table 13. AstraZeneca Panic Disorders Total Revenue (USD Million) (2018-2019)
Table 14. AstraZeneca SWOT Analysis
Table 15. AstraZeneca Panic Disorders Product and Solutions
Table 16. AstraZeneca Panic Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sun Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Sun Pharmaceuticals Panic Disorders Major Business
Table 19. Sun Pharmaceuticals Panic Disorders Total Revenue (USD Million) (2017-2018)
Table 20. Sun Pharmaceuticals SWOT Analysis
Table 21. Sun Pharmaceuticals Panic Disorders Product and Solutions
Table 22. Sun Pharmaceuticals Panic Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Mylan Corporate Information, Location and Competitors
Table 24. Mylan Panic Disorders Major Business
Table 25. Mylan Panic Disorders Total Revenue (USD Million) (2017-2018)
Table 26. Mylan SWOT Analysis
Table 27. Mylan Panic Disorders Product and Solutions
Table 28. Mylan Panic Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Global Panic Disorders Revenue (Million USD) by Players (2015-2020)
Table 30. Global Panic Disorders Revenue Share by Players (2015-2020)
Table 31. Global Panic Disorders Revenue (Million USD) by Regions (2015-2020)
Table 32. Global Panic Disorders Revenue Market Share by Regions (2015-2020)
Table 33. North America Panic Disorders Revenue by Countries (2015-2020)
Table 34. North America Panic Disorders Revenue Market Share by Countries (2015-2020)
Table 35. Europe Panic Disorders Revenue (Million USD) by Countries (2015-2020)
Table 36. Asia-Pacific Panic Disorders Revenue (Million USD) by Countries (2015-2020)
Table 37. South America Panic Disorders Revenue by Countries (2015-2020)
Table 38. South America Panic Disorders Revenue Market Share by Countries (2015-2020)
Table 39. Middle East and Africa Panic Disorders Revenue (Million USD) by Countries (2015-2020)
Table 40. Middle East and Africa Panic Disorders Revenue Market Share by Countries (2015-2020)
Table 41. Global Panic Disorders Revenue (Million USD) by Type (2015-2020)
Table 42. Global Panic Disorders Revenue Share by Type (2015-2020)
Table 43. Global Panic Disorders Revenue Forecast by Type (2021-2025)
Table 44. Global Panic Disorders Revenue by Application (2015-2020)
Table 45. Global Panic Disorders Revenue Share by Application (2015-2020)
Table 46. Global Panic Disorders Revenue Forecast by Application (2021-2025)
Table 47. Global Panic Disorders Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Panic Disorders Picture
Figure 2. Global Panic Disorders Revenue Market Share by Type in 2019
Figure 3. Anti-Depressants Picture
Figure 4. Benzodiazepines Picture
Figure 5. Panic Disorders Revenue Market Share by Application in 2019
Figure 6. Hospital Pharmacies Picture
Figure 7. Retail Pharmacies Picture
Figure 8. Drug Stores Picture
Figure 9. E-Commerce Picture
Figure 10. Global Panic Disorders Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Panic Disorders Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Panic Disorders Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Panic Disorders Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Panic Disorders Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Panic Disorders Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Panic Disorders Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Panic Disorders Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Panic Disorders Revenue Market Share in 2019
Figure 19. Global Top 10 Players Panic Disorders Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Panic Disorders Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Panic Disorders Revenue Market Share by Regions (2015-2020)
Figure 23. Global Panic Disorders Revenue Market Share by Regions in 2018
Figure 24. North America Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 25. Europe Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 27. South America Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 29. North America Panic Disorders Revenue Market Share by Countries (2015-2020)
Figure 30. North America Panic Disorders Revenue Market Share by Countries in 2019
Figure 31. USA Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 32. Canada Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 34. Europe Panic Disorders Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Panic Disorders Revenue Market Share by Countries in 2019
Figure 36. Germany Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 37. UK Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 38. France Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 39. Russia Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 40. Italy Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Panic Disorders Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Panic Disorders Revenue Market Share by Countries in 2019
Figure 43. China Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 44. Japan Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 45. Korea Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 46. India Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 48. South America Panic Disorders Revenue Market Share by Countries (2015-2020)
Figure 49. South America Panic Disorders Revenue Market Share by Countries in 2019
Figure 50. Brazil Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Panic Disorders Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Panic Disorders Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 55. UAE Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Panic Disorders Revenue and Growth Rate (2015-2020)
Figure 58. Global Panic Disorders Revenue Share by Type (2015-2020)
Figure 59. Global Panic Disorders Revenue Share by Type in 2019
Figure 60. Global Panic Disorders Market Share Forecast by Type (2021-2025)
Figure 61. Global Anti-Depressants Revenue Growth Rate (2015-2020)
Figure 62. Global Benzodiazepines Revenue Growth Rate (2015-2020)
Figure 63. Global Panic Disorders Revenue Share by Application (2015-2020)
Figure 64. Global Panic Disorders Revenue Share by Application in 2019
Figure 65. Global Panic Disorders Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 67. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 68. Global Drug Stores Revenue Growth Rate (2015-2020)
Figure 69. Global E-Commerce Revenue Growth Rate (2015-2020)
Figure 70. Global Panic Disorders Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Panic Disorders Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Panic Disorders Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Panic Disorders Revenue Market Forecast (2021-2025)
Figure 74. Europe Panic Disorders Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Panic Disorders Revenue Market Forecast (2021-2025)
Figure 76. South America Panic Disorders Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Panic Disorders Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel